National Multiple Sclerosis Society (NMSS) is a corporate venture arm. The known portfolio counts 7 companies, including Clene Nanomedicine, InFlectis BioScience, Myrobalan Therapeutics, BrainStorm Cell Therapeutics, Longevity Biotech and Neurogenesis.
Is National Multiple Sclerosis Society (NMSS) a fit for your startup?
Paste your website. AI checks the fit and scores every other investor too.
Investment focus
- Sector
- Healthcare
- Focus
- BiotechCell TherapyDigital HealthDrug DiscoveryFoundationNeuroscience
Contacts
National Multiple Sclerosis Society (NMSS) portfolio companies (7)
- Clene Nanomedicine
- InFlectis BioScience
- Myrobalan Therapeutics
- BrainStorm Cell Therapeutics
- Longevity Biotech
- Neurogenesis
- eSupport Health
Co-investors
Funds that share portfolio companies with National Multiple Sclerosis Society (NMSS).
Similar funds
Showing 20 of 100
About National Multiple Sclerosis Society (NMSS)
The firm's listing covers sector Healthcare, and focus areas Biotech, Cell Therapy, Digital Health and Drug Discovery; known deals cluster at Seed and Series A.
Across the known portfolio, 3 co-investors appear alongside National Multiple Sclerosis Society (NMSS), including The ALS Association, Maryland Department of Housing and Community Development and Boxer Capital Management.
Frequently asked questions
What is National Multiple Sclerosis Society (NMSS)?
National Multiple Sclerosis Society (NMSS) is a corporate venture arm with a known portfolio of 7 companies. The portfolio comes from public investment records rather than from the firm, so deals that never surfaced publicly are not in it.
What does National Multiple Sclerosis Society (NMSS) invest in?
Listed sectors include Healthcare; listed focus areas include Biotech, Cell Therapy, Digital Health and Drug Discovery. Those tags come from the portfolio attached to the firm, so they describe what has been backed rather than a stated mandate for what comes next.
What stage does National Multiple Sclerosis Society (NMSS) invest at?
The known deals of National Multiple Sclerosis Society (NMSS) include Seed and Series A rounds. Check that against your own round before reaching out: stage mismatch is the most common reason a well matched sector still goes nowhere.
How do I contact National Multiple Sclerosis Society (NMSS)?
Any email address on file for the firm is masked on this page and readable inside RaiseHunt after you create an account.
Skip the browsing. Let AI find your ideal investors in one minute.
Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.
Data: RaiseHunt investor dataset · Snapshot 5 September 2026 · How this data is built · Report a correction or request removal